Dermaseptin B2 can bind to the plasma membrane of human PC3 cancer cells, aggregate on and penetrate the cells, resulting in a necrotic-like pathway which ruptures the cancer cell membrane due to alteration in the mitochondrial membrane potential and stimulation of caspase-3 [34]. This evidence concerns the gene CASP3 and cancer.